ON THIS PAGE: You will find information about how many people are diagnosed with this type of cancer each year and some general survival information. Remember, survival rates depend on several factors. To see other pages, use the menu on the side of your screen.
Primary bile duct cancer is uncommon. Each year, an estimated 2,000 to 3,000 people in the United States are diagnosed with bile duct cancer. The number of new cases of bile duct cancer is increasing, mostly due to rising rates of intrahepatic bile duct cancer. The reason for this increase is not known. It may be due to the use of more accurate tests to diagnose this type of cancer. Previously, intrahepatic bile duct cancer may have been thought to be a different type of cancer.
In some parts of the world, a parasite called a liver fluke can infect the bile duct and cause cancer. Liver flukes are very common in Asia and the Middle East, and therefore bile duct cancer is more common in these regions. Also, gallstones and inflammatory conditions of the digestive tract, such as ulcerative colitis or an associated condition called primary sclerosing cholangitis (PSC), increase the risk of bile duct cancer. PSC is an autoimmune disease in which the body's immune system attacks the bile ducts and causes scarring, See the Risk Factors  section for more information.
The five-year survival rate is the percentage of people who survive at least five years after the cancer is found. The five-year survival rate of people with early-stage extrahepatic cancer is 30%. If the cancer has spread to the regional lymph nodes, the five-year survival rate is 24%. If the cancer has spread to a distant part of the body, the five-year survival rate is 2%.
For people with early-stage intrahepatic cancer, the five-year survival rate is 15%. If the cancer has spread to the regional lymph nodes, the five-year survival rate is 6%. If the cancer has spread to a distant part of the body, the five-year survival rate is 2%.
Cancer survival statistics should be interpreted with caution. Estimates are based on data from many people with this type of cancer in the United States, so the actual risk for a particular person may be different. It is not possible to tell a person how long he or she will live with bile duct cancer. Because the survival statistics are measured in five-year intervals, they may not represent advances made in the treatment or diagnosis of this cancer. Learn more about understanding statistics .
Source: American Cancer Society website.
To continue reading this guide, use the menu on the left side of your screen to choose another section.